Ferrán Losa

2.0k total citations
70 papers, 1.1k citations indexed

About

Ferrán Losa is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ferrán Losa has authored 70 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 22 papers in Surgery and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ferrán Losa's work include Colorectal Cancer Treatments and Studies (48 papers), Cancer Treatment and Pharmacology (19 papers) and Colorectal Cancer Surgical Treatments (18 papers). Ferrán Losa is often cited by papers focused on Colorectal Cancer Treatments and Studies (48 papers), Cancer Treatment and Pharmacology (19 papers) and Colorectal Cancer Surgical Treatments (18 papers). Ferrán Losa collaborates with scholars based in Spain, United States and Australia. Ferrán Losa's co-authors include Antonieta Salud, Enrique Aranda, P. Escudero, Carles Pericay, Joan Maurel, Bartomeu Massutí, Encarnación González‐Flores, María José Safont, Fernando Rivera and Alfredo Carrato and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Ferrán Losa

65 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ferrán Losa Spain 17 939 361 300 241 196 70 1.1k
Rosella Spadi Italy 13 1.1k 1.1× 358 1.0× 489 1.6× 193 0.8× 324 1.7× 28 1.4k
Keiichiro Kanemitsu Japan 17 882 0.9× 705 2.0× 466 1.6× 31 0.1× 130 0.7× 52 1.2k
Shunsuke Tsukamoto Japan 18 720 0.8× 412 1.1× 286 1.0× 109 0.5× 78 0.4× 92 1.0k
Yuichi Arimoto Japan 13 376 0.4× 429 1.2× 313 1.0× 102 0.4× 66 0.3× 35 1.0k
H. Ulrich-Pur Austria 17 707 0.8× 263 0.7× 370 1.2× 40 0.2× 107 0.5× 29 951
Yasuharu Ikeda Japan 21 574 0.6× 585 1.6× 385 1.3× 45 0.2× 464 2.4× 62 1.4k
Wilson Luiz da Costa Brazil 14 403 0.4× 291 0.8× 364 1.2× 52 0.2× 94 0.5× 68 785
L Herrera United States 12 1.1k 1.2× 398 1.1× 407 1.4× 488 2.0× 106 0.5× 28 1.5k
Jason S. Starr United States 14 643 0.7× 272 0.8× 224 0.7× 122 0.5× 121 0.6× 79 1.0k
Atin Agarwal United States 9 1.1k 1.2× 625 1.7× 346 1.2× 376 1.6× 267 1.4× 19 1.4k

Countries citing papers authored by Ferrán Losa

Since Specialization
Citations

This map shows the geographic impact of Ferrán Losa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferrán Losa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferrán Losa more than expected).

Fields of papers citing papers by Ferrán Losa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferrán Losa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferrán Losa. The network helps show where Ferrán Losa may publish in the future.

Co-authorship network of co-authors of Ferrán Losa

This figure shows the co-authorship network connecting the top 25 collaborators of Ferrán Losa. A scholar is included among the top collaborators of Ferrán Losa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferrán Losa. Ferrán Losa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Grávalos, Cristina, Fernando Pereira, Ruth Vera, et al.. (2023). Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement. Clinical & Translational Oncology. 25(12). 3378–3394. 2 indexed citations
3.
Elez, Élena, Cristina Grávalos, Pilar García‐Alfonso, et al.. (2023). A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients. Biomedicine & Pharmacotherapy. 159. 114272–114272. 8 indexed citations
4.
5.
Losa, Ferrán, et al.. (2023). Determining the optimal interval between neoadjuvant radiochemotherapy and surgery in rectal cancer: a retrospective cohort study. International Journal of Colorectal Disease. 38(1). 154–154. 2 indexed citations
6.
Mezheyeuski, Artur, Patrick Micke, J.C. Ruffinelli, et al.. (2022). Spatial Immunology in Liver Metastases from Colorectal Carcinoma according to the Histologic Growth Pattern. Cancers. 14(3). 689–689. 3 indexed citations
7.
Losa, Ferrán, et al.. (2022). 408P Prediction of survival using the G8 scale frailty scale in a prospective series of elderly patients with colon cancer. Annals of Oncology. 33. S723–S723. 1 indexed citations
8.
Vidal, Joana, David Casadevall, Beatríz Bellosillo, et al.. (2021). Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial. Clinical Cancer Research. 27(10). 2890–2898. 62 indexed citations
9.
Pauli, Chantal, Tilmann Bochtler, Linda Mileshkin, et al.. (2021). A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience. The Oncologist. 26(5). e769–e779. 38 indexed citations
10.
Losa, Ferrán, et al.. (2021). Short-course radiotherapy in stage IV rectal cancer with resectable disease. Clinical & Translational Oncology. 23(12). 2482–2488.
11.
Elez, Élena, Cristina Grávalos, Pilar García‐Alfonso, et al.. (2021). Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial. British Journal of Cancer. 126(6). 874–880. 5 indexed citations
12.
Losa, Ferrán, L. Iglesias, Victòria Fusté, et al.. (2018). 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary. Clinical & Translational Oncology. 20(11). 1361–1372. 30 indexed citations
13.
Matías‐Guiu, Xavier, Victòria Fusté, L. Iglesias, et al.. (2018). Consenso 2018 de la Sociedad Española de Anatomía Patológica y la Sociedad Española de Oncología Médica sobre el diagnóstico y tratamiento del cáncer de origen desconocido. Revista Española de Patología. 52(1). 33–44.
14.
Carrato, Alfredo, Albert Abad, Bartomeu Massutí, et al.. (2017). First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD). European Journal of Cancer. 81. 191–202. 62 indexed citations
15.
Losa, Ferrán, P. Barrios, Ramón Salazar, et al.. (2013). Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin. Clinical & Translational Oncology. 16(2). 128–140. 22 indexed citations
16.
Salazar, Ramón, Matilde Navarro, Ferrán Losa, et al.. (2012). Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II–III rectal cancer. Clinical & Translational Oncology. 14(8). 592–598. 4 indexed citations
17.
Alonso, Vicente, Carles Pericay, P. Escudero, et al.. (2010). Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer. Chemotherapy. 56(2). 142–146. 18 indexed citations
18.
Sastre, Javier, Enrique Aranda, Bartomeu Massutí, et al.. (2008). Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: Comparative outcomes from the 03-TTD-01 phase III study. Critical Reviews in Oncology/Hematology. 70(2). 134–144. 40 indexed citations
19.
Feliú, Jaime, Antonieta Salud, P. Escudero, et al.. (2006). XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer. British Journal of Cancer. 94(7). 969–975. 80 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosella Spadi Breakdown of academic impact, for papers by Keiichiro Kanemitsu Breakdown of academic impact, for papers by Shunsuke Tsukamoto Breakdown of academic impact, for papers by Yuichi Arimoto Breakdown of academic impact, for papers by H. Ulrich-Pur Breakdown of academic impact, for papers by Yasuharu Ikeda Breakdown of academic impact, for papers by Wilson Luiz da Costa Breakdown of academic impact, for papers by L Herrera Breakdown of academic impact, for papers by Jason S. Starr Breakdown of academic impact, for papers by Atin Agarwal
Rankless by CCL
2026